Hoang Peter L.
Insider CIK 1626893 · TPIV President and CEO, Director · BLCM Sr. VP of Bus. Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRKR Marker Therapeutics, Inc. | F Tax w/h | 2022-03-24 | 2022-03-28 | 48,376 | $0.48 | $23.2K | 483,286 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | A Award | 2022-03-24 | 2022-03-28 | 199,094 | — | $0 | 531,662 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | A Award deriv | 2022-02-17 | 2022-02-22 | 430,000 | — | $0 | 430,000 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2021-03-16 | 2021-03-18 | 142,857 | $1.75 | $250.0K | 332,568 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | A Award deriv | 2021-02-11 | 2021-02-12 | 430,000 | — | $0 | 430,000 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | A Award deriv | 2020-03-10 | 2020-03-12 | 388,800 | — | $0 | 388,800 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | A Award deriv | 2020-03-10 | 2020-03-12 | 41,200 | — | $0 | 41,200 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2019-08-14 | 2019-08-15 | 10,000 | $4.62 | $46.2K | 189,711 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | A Award deriv | 2018-10-19 | 2018-10-23 | 1,359,855 | — | $0 | 1,359,855 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | A Award deriv | 2018-10-19 | 2018-10-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| TPIV TAPIMMUNE INC. | F Tax w/h | 2017-09-22 | 2017-09-25 | 70,289 | $3.18 | $223.5K | 179,711 | SEC↗ |
| TPIV TAPIMMUNE INC. | A Award | 2017-09-22 | 2017-09-25 | 250,000 | $3.18 | $795.0K | 250,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 11,250 | — | $0 | 11,250 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 6,250 | — | $0 | 6,250 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-01-04 | 2016-01-06 | 37,500 | — | $0 | 37,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2015-02-24 | 2015-02-26 | 60,000 | — | $0 | 60,000 | SEC↗ |